RT + immunotherapy = head/neck cancer treatment option
February 28, 2020 -- A combination of radiation therapy and immunotherapy shows promise for patients with recurring or metastatic head and neck squamous cell carcinoma, according to a presentation delivered on February 28 at the Multidisciplinary Head and Neck Cancers Symposium in Scottsdale, AZ.  Discuss
Isotopia, Eckert & Ziegler partner
February 18, 2020 -- Isotopia Molecular Imaging has partnered with isotope technology firm Eckert & Ziegler for the development of its PSMA-11 kit for prostate cancer imaging.
Being active may improve radiation therapy outcomes
February 14, 2020 -- Patients who are physically active before they undergo thoracic radiation therapy may have better outcomes, according to study results delivered at a meeting on the cardiovascular care of oncology patients held by the American College of Cardiology.  Discuss
ASTRO nabs VA contract to create quality indicators
February 14, 2020 -- The U.S. Department of Veterans Affairs (VA) has awarded a one-year contract to the American Society for Radiation Oncology (ASTRO) to develop quality indicators for radiation oncology treatments.
Q BioMed debuts radiopharmaceutical for cancer pain
February 14, 2020 -- Biotech company Q BioMed has debuted a new therapeutic radiopharmaceutical to treat cancer-related pain.
MIM Software, Sitex team up to treat cancer
February 12, 2020 -- Medical imaging software developer MIM Software will collaborate with radiation oncology firm Sirtex Medical to distribute yttrium-90 (Y-90) microspheres and related products around the world.
iCAD reports Xoft Axxent milestone
February 12, 2020 -- Computer-aided detection (CAD) software developer iCAD said that its Xoft Axxent electronic brachytherapy system has been used to treat a metastatic brain tumor in the U.S. for the first time.
Varian gets FDA nod for Ethos adaptive therapy unit
February 11, 2020 -- Radiation therapy firm Varian Medical Systems has garnered U.S. Food and Drug Administration (FDA) clearance for its Ethos system, a radiation therapy platform that utilizes artificial intelligence to adapt treatments in real-time to changes in tumors and patient anatomy.
International Isotopes receives FDA nod for I-131
February 11, 2020 -- Radioisotope manufacturer International Isotopes received clearance from the U.S. Food and Drug Administration (FDA) for use of its sodium iodide-131 (I-131) radiopharmaceutical to treat hyperthyroidism and thyroid carcinomas.
Akesis gets FDA clearance for radiosurgery system
February 7, 2020 -- Radiation therapy developer Akesis has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Akesis Galaxy RTx radiosurgery system.
Special Feature
IMV: Imaging boosts precision in radiation therapy

Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more